- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04533204
Mnemonic Strategy Versus Spaced Retrieval Training in Those With Mild Cognitive Impairment (MST training)
February 26, 2021 updated by: VA Office of Research and Development
Comparing Mnemonic Strategy With Spaced Retrieval Training in Patients With Mild Cognitive Impairment (B6366-W)
This study compared two active cognitive interventions to evaluate whether one improved memory more than the other in patients with mild cognitive impairment.
Participants were randomized to either memory strategy training or spaced retrieval training and completed memory tests before and after 3 training sessions.
Participants returned 1 month after treatment to see how well they remembered the learned information.
Brain scans (functional MRI) were collected before and after the interventions to see if training changed the way brain regions were functioning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Individuals with MCI were randomized to 3 sessions of mnemonic strategy or spaced retrieval training that focused on object location associations.
Across these training sessions, each group received 9 training trials for each of the 45 trained stimuli.
Task-fMRI was acquired before and after training.
Memory was again evaluated 1 month after the last training session.
The primary outcome measure was memory for the "trained" stimuli while secondary outcome was accuracy for novel stimuli acquired outside of the MRI environment.
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48105
- VA Ann Arbor Healthcare System, Ann Arbor, MI
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
-Diagnosis of MCI according to Petersen (2004) criteria, right handed
Exclusion Criteria:
- Diagnosis of other neurological condition,
- active drug/alcohol abuse/dependence,
- moderate-severe depression or other Axis I diagnoses.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mnemonic strategy training
Training using mnemonic strategies
|
training using mnemonic strategies
|
Active Comparator: Spaced retrieval training
Training using spaced retrieval
|
training using spaced retrieval
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of Correct Object Location Associations Assessed up to 1 Month Post-treatment
Time Frame: up to 1 month after last training session
|
Change in memory for 45 trained object location associations
|
up to 1 month after last training session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Accuracy (vs. Baseline) on Novel Object Location Associations
Time Frame: up to 1 month after last training session
|
Change in accuracy for novel object location associations using a touchscreen task; distance measured in cm from actual location
|
up to 1 month after last training session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Benjamin M. Hampstead, PhD, VA Ann Arbor Healthcare System, Ann Arbor, MI
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2010
Primary Completion (Actual)
June 30, 2014
Study Completion (Actual)
July 30, 2014
Study Registration Dates
First Submitted
August 25, 2020
First Submitted That Met QC Criteria
August 25, 2020
First Posted (Actual)
August 31, 2020
Study Record Updates
Last Update Posted (Actual)
March 23, 2021
Last Update Submitted That Met QC Criteria
February 26, 2021
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6366-W-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on mnemonic strategy training
-
VA Office of Research and DevelopmentEmory UniversityCompletedTraumatic Brain Injury | Mild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Bar-Ilan University, IsraelCompletedCognitive DeclineIsrael
-
Sultan Qaboos UniversityCompletedTraumatic Brain Injury | EducationOman
-
University of New MexicoCompletedPatient Satisfaction | Fecal Incontinence | CounsellingUnited States
-
MGH Institute of Health ProfessionsLSVT GlobalCompleted
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
University of PittsburghCompletedStroke | Adherence, Patient | Strategy TrainingUnited States
-
University of PittsburghRecruiting
-
Taipei Medical UniversityActive, not recruitingStroke | Cognitive ImpairmentTaiwan
-
Taipei Medical UniversityActive, not recruitingStroke | Cognitive Impairment | Acquired Brain InjuryTaiwan